Zavante Therapeutics, Inc.
Edit

Zavante Therapeutics, Inc.

http://www.zavante.com/
Tags:BiopharmaDevelopmentLearnMedicalMedTechProductResearch
Nabriva is a commercial-stage biopharmaceutical company engaged in the research & development of novel antibiotics to treat serious infections, with a current focus on the pleuromutilin class of antibiotics. Learn more at Nabriva.com
Location: United States, California, San Diego
Total raised: $65M

Investors 1

Funding Rounds 3

DateSeriesAmountInvestorsDeal News
01.09.2016-$10M-finsmes.co...
30.03.2016Series A$45M-socaltech....
23.12.2015-$10M-medcitynew...

Mentions in press and media 12

DateTitleDescriptionCategoryAuthorSource
27.03.2017A lot to G...It was that dire lack of optio...--medcitynew...
01.09.2016Zavante Th...Zavante Therapeutics, a San Di...USA-finsmes.co...
01.09.2016Zavante Th...Zavante Therapeutics, a San Di...--sdbj.com/n...
30.03.2016Zavante ra...However, there’s nothing like ...--medcitynew...
30.03.2016Zavante Th... SAN DIEGO, CA, Privately hel...--vcnewsdail...
30.03.2016 Zavant...San Diego-based Zavante Therap...--socaltech....
30.03.2016Daily fund...Zavante closed $45M Series A f...-Mitos Suso...vator.tv/n...
30.03.2016Zavante Th...Zavante Therapeutics, Inc., a ...USA-finsmes.co...
23.12.2015Zavante ge...Zavante says that ZTI-01 is a ...--medcitynew...
-Zavante ge...With a new $10 million equity ...--medcitynew...
Show more